USE OF (4-HYDROXY-2-METHYL-1,1-DIOXIDO-2H-BENZO [E] [1,2] THIAZIN-3-YL) (NAPHTHALEN-2-YL) METHANONE IN THE PREVENTION AND / OR TREATMENT OF NON-ALCOHOLIC STEATOHEPATITIS
- 专利权人:
- PIERRE FABRE MEDICAMENT
- 发明人:
- MARIE LAMOTHE,DIDIER JUNQUERO,BRUNO LE GRAND
- 申请号：
- FR1553574
- 公开号：
- FR3035326B1
- 申请日:
- 2015.04.21
- 申请国别(地区):
- FR
- 年份:
- 2017
- 代理人:
- 摘要：
- The present invention relates to (4-hydroxy-2-methyl-1,1-dioxido-2H-benzo[e][1,2]thiazine-3-yl)(naphthalen-2-yl)methanone or one of the salts thereof, pharmaceutically acceptable for use in the prevention and/or treatment of hepatic steatosis, including non-alcoholic steatohepatitis or one of the complications of same.
- 来源网站：
- 中国工程科技知识中心
相关发明人
相关专利
- Use of (4-hydroxy-2-methyl-1,1-dioxido-2H-benzo(e)(1,2)thiazine-3-yl)(naphthalene-2-yl) methanone in the prevention and/or treatment of non-alcoholic steatohepatitis
- USE OF (4-HYDROXY-2-METHYL-1,1-DIOXIDO-2H-BENZO[E][1,2]THIAZINE-3-YL)(NAPHTHALENE-2-YL) METHANONE IN THE PREVENTION AND/OR TREATMENT OF NON-ALCOHOLIC STEATOHEPATITIS
- (4-Hydroxy-2-methyl-1,1-dioxide-2H-benzo [e] [1,2] thiazin-3-yl) (naphthalene-2-yl) in the prevention and / or treatment of nonalcoholic steatohepatitis Il) Use of Methanone
- DIAGNOSTICS AND METHODS FOR TREATMENT OF NON-ALCOHOLIC HEPATIC STEATOSIS AND HEPATIC STEATOHEPATITIS, AND PREVENTION OF COMPLICATIONS THEREOF
- DIAGNOSTICS AND METHODS FOR TREATMENT OF NON-ALCOHOLIC HEPATIC STEATOSIS AND HEPATIC STEATOHEPATITIS, AND PREVENTION OF COMPLICATIONS THEREOF
